| First Author | Peng Z | Year | 2023 |
| Journal | iScience | Volume | 26 |
| Issue | 1 | Pages | 105909 |
| PubMed ID | 36691613 | Mgi Jnum | J:332859 |
| Mgi Id | MGI:7430475 | Doi | 10.1016/j.isci.2022.105909 |
| Citation | Peng Z, et al. (2023) PKR deficiency delays vascular aging via inhibiting GSDMD-mediated endothelial cell hyperactivation. iScience 26(1):105909 |
| abstractText | Vascular aging is an independent risk factor for cardiovascular diseases, but the regulatory mechanism is not clearly understood. In this study, we found that endothelial PKR activity is elevated in aging aorta tissues, which is accompanied with increased endothelial cell hyperactivation, IL-1beta and HMGB1 release and vascular smooth muscle cell (VSMC) phenotype transforming. Global knockout of PKR exhibits significantly delayed vascular aging compared to wild-type mice at the same age. In vitro, using PKR siRNA or the cell hyperactivation inhibitor glycine or disulfiram can effectively inhibit H(2)O(2) or palmitic acid-induced endothelial cell hyperactivation, IL-1beta and HMGB1 release and co-cultured VSMC phenotype transforming. These results demonstrate that endothelial PKR activation induces GSDMD-mediated endothelial cell hyperactivation to release HMGB1 and IL-1beta, which promotes the phenotype transforming of VSMC and subsequent accelerates the process of vascular aging. These discoveries will help to explore the new drug target to inhibit vascular aging. |
